Hamish continues, “By combining IBM’s support for SMEs and their technology expertise with Whitespace’s knowledge of innovation engineering, we are well-positioned to take on this exciting challenge. Our goal is to find high-potential technology companies with relevant experience in digital pathology and histology, or that have a background in developing ML Vision technology for healthcare and related industries, that want to work with pathologists to help address challenges in the UK. The successful applicants will be given the opportunity to showcase their product to the NHS and associated data hubs.”
Deborah Threadgold, Vice President of Next-Generation Ecosystem, EMEA at IBM, adds: “IBM is passionate about supporting collaboration amongst technology providers. We have seen time and again that there is no challenge too great if we combine the right capabilities and technology from partners across the ecosystem. We are proud to be working with Whitespace and Pfizer on this Tech Innovation Challenge and look forward to a new breed of advancements in AI in the UK Healthcare industry from those who take up the challenge.”
Andrew Webber, Chief Marketing Officer at Whitespace, concludes: “As is becoming increasingly the case in this day and age, ambitious and high growth technology companies have a crucial role to play in collaborating with corporates to support technological innovation. It is extremely encouraging that Pfizer and IBM share this vision as global leaders in healthcare and technology.”
PP-INP-GBR-0144 – October 2020